Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for PAVmed Inc. (PAVM : NSDQ)

• Company Description    PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City. Number of Employees: 39

• Price / Volume Information    Yesterday's Closing Price: $0.43 Daily Weekly Monthly 20 Day Moving Average: 254,304 shares Shares Outstanding: 21.93 (millions) Market Capitalization: $9.39 (millions) Beta: 1.09 52 Week High: $1.90 52 Week Low: $0.30 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -6.20% -7.90% 12 Week -29.85% -36.31% Year To Date -31.81% -39.12%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 360 MADISON AVENUE 25TH FLOOR - NEW YORK,NY 10017 USA ph: 917-813-1828 fax: - mjr@pavmed.com http://www.pavmed.com

• General Corporate Information    Officers Lishan Aklog - Chief Executive Officer and Chairman Michael J. Glennon - Vice Chairman Dennis M. McGrath - President and Chief Financial Officer Debra J. White - Director Ronald M. Sparks - Director Peer Information PAVmed Inc. (ABMD) PAVmed Inc. (DMDS) PAVmed Inc. (CPWY.) PAVmed Inc. (EQUR) PAVmed Inc. (ECIA) PAVmed Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 70387R403 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/12/25 Share - Related Items Shares Outstanding: 21.93 Most Recent Split Date: 12.00 (0.07:1) Beta: 1.09 Market Capitalization: $9.39 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.31 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.07 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.44 Price/Cash Flow: - Price / Sales: 9.20 EPS Growth vs. Year Ago Period: 92.86% vs. Previous Quarter: 57.14% Sales Growth vs. Year Ago Period: -99.39% vs. Previous Quarter: -25.00% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - -20.96 03/31/25 - -42.29 12/31/24 - -66.68 Current Ratio 06/30/25 - 0.52 03/31/25 - 0.37 12/31/24 - 0.06 Quick Ratio 06/30/25 - 0.52 03/31/25 - 0.37 12/31/24 - 0.06 Operating Margin 06/30/25 - -811.18 03/31/25 - -814.05 12/31/24 - -767.38 Net Margin 06/30/25 - 7,144.80 03/31/25 - 3,711.54 12/31/24 - 1,328.58 Pre-Tax Margin 06/30/25 - 6,681.57 03/31/25 - 3,289.61 12/31/24 - 949.15 Book Value 06/30/25 - 0.18 03/31/25 - 0.74 12/31/24 - -0.92 Inventory Turnover 06/30/25 - 1,004.67 03/31/25 - 18.08 12/31/24 - 17.55 Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - - Debt-to-Capital 06/30/25 - 10.38 03/31/25 - 4.89 12/31/24 - -

Powered by Zacks Investment Research ©